Suchergebnisse - "Ritonavir"

PubPharm (2.589)

21

Dose optimization with population pharmacokinetics of ritonavir-boosted lopinavir for Thai people living with HIV with and without active tuberculosis

enthalten in: Drug metabolism and pharmacokinetics | 2022

von Chaivichacharn, P. | Avihingsanon, A. | Gatechompol, S. | +2

22

Safety and Tolerability of Paxlovid (Nirmatrelvir/Ritonavir) in High-risk Patients

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Pesko, B. | Deng, A. | Chan, J. | +3

CommentOn: Clin Infect Dis. 2022 Jun 02;:null. - PMID 35653428

23

Durability of switched therapy after failure of WHO-recommended antiretroviral therapy regimens in a resource-limited setting

enthalten in: AIDS (London, England) | 2022

von Lumu, I. | Musaazi, J. | Castelnuovo, B.

24

Discovery of Novel HIV Protease Inhibitors Using Modern Computational Techniques

enthalten in: International journal of molecular sciences | 2022

von Okafor, S. | Angsantikul, P. | Ahmed, H.

25

The effect of protease inhibitors-based antiretroviral therapy on serum/plasma interleukin-6 levels among PLHIV : a systematic review and meta-analysis

enthalten in: Journal of medical virology | 2022

von Ashuro, A. | Zhang, S. | Wang, T. | +4

26

Recent advances in nanoformulation development of Ritonavir, a key protease inhibitor used in the treatment of HIV-AIDS

enthalten in: Expert opinion on drug delivery | 2022

von Jitta, S. | Salwa | Bhaskaran, N. | +2

27

Can transcription factors in the intervertebral disc of lopinavir/ritonavir prevent degeneration in the nucleus pulposus by mediating the regulation of inflammation through signaling pathways?

enthalten in: European review for medical and pharmacological sciences | 2022

von Yilmaz, I. | Akalan, H. | Karaarslan, N. | +5

28

Long-acting HIV fusion inhibitor albuvirtide combined with ritonavir-boosted lopinavir for HIV-1-infected patients after failing the first-line antiretroviral therapy : 48-week randomized, controlled, phase 3 non-inferiority TALENT study

enthalten in: The Journal of infection | 2022

von Su, B. | Yao, C. | Zhao, Q. | +37

29

Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States

enthalten in: The New England journal of medicine | 2022

von Patel, K. | Huo, Y. | Jao, J. | +114

30

Yes We Can (Use Nirmatrelvir/Ritonavir Even in High Immunological Risk Patients Treated with Immunosuppressive Drugs)!

enthalten in: Clinical pharmacokinetics | 2022

von Lemaitre, F.